Cronos Group Inc.
Cronos Group Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 822 | 792 | 784 | 794 | 798 | 859 | 862 | 848 | 855 | 669 | 572 | 409 | |||||
Short Term Investments | 0 | 40 | 40 | 40 | 40 | 0 | 0 | 0 | 0 | 192 | 268 | 432 | |||||
Accounts Receivable Net Current | 33 | 34 | 27 | 27 | 19 | 15 | 20 | 16 | 15 | 14 | 16 | 13 | |||||
Interest Receivable Current | 6 | 9 | 7 | 3 | 5 | 9 | 7 | 5 | 4 | 10 | 12 | 9 | |||||
Assets Current | |||||||||||||||||
Assets Current | 928 | 944 | 922 | 927 | 919 | 936 | 959 | 935 | 942 | 933 | 918 | 925 | |||||
Other Receivables Net Current | 14 | 14 | 4 | 10 | 7 | 5 | 6 | 7 | 6 | 6 | 5 | 5 | |||||
Notes And Loans Receivable Net Current | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 5 | 6 | 6 | 5 | 5 | |||||
Inventory Net | 49 | 47 | 48 | 42 | 35 | 33 | 47 | 29 | 31 | 30 | 36 | 45 | |||||
Prepaid Expense And Other Assets Current | 5 | 8 | 9 | 5 | 6 | 6 | 7 | 5 | 6 | 5 | 6 | 7 | |||||
Assets Held For Sale Not Part Of Disposal Group Cu… | - | 0 | 3 | 6 | 8 | 8 | 9 | 19 | 19 | 0 | - | - | |||||
Other Long Term Investments | 5 | 8 | 11 | 2 | 3 | 3 | 3 | 3 | 20 | 35 | 62 | 68 | |||||
Equity Method Investments | - | - | - | - | - | 0 | 0 | 21 | 21 | 19 | 18 | 18 | |||||
Notes And Loans Receivable Net Noncurrent | 21 | 21 | 22 | 14 | 16 | 16 | 16 | 73 | 67 | 69 | 68 | 71 | |||||
Property Plant And Equipment Net | 142 | 146 | 146 | 150 | 139 | 133 | 163 | 37 | 37 | 59 | 56 | 58 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |||||
Goodwill | 65 | 66 | 65 | 67 | 63 | 63 | 38 | 1 | 1 | 1 | 1 | 1 | |||||
Intangible Assets Net Excluding Goodwill | 9 | 9 | 10 | 11 | 11 | 11 | 4 | 19 | 20 | 21 | 24 | 25 | |||||
Other Assets Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | - | |||||
Deferred Income Tax Assets Net | 1 | 2 | 0 | 3 | 3 | 3 | - | - | - | 0 | 1 | 1 | |||||
Assets | 1,172 | 1,197 | 1,178 | 1,175 | 1,154 | 1,166 | 1,184 | 1,091 | 1,109 | 1,140 | 1,150 | 1,168 | |||||
Liabilities | |||||||||||||||||
Accounts Payable Current | 10 | 12 | 11 | 12 | 9 | 17 | 7 | 8 | 9 | 12 | 5 | 9 | |||||
Accrued Income Taxes Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
Liabilities Current | |||||||||||||||||
Accrued Liabilities Current | 31 | 36 | 30 | 25 | 23 | 32 | 32 | 24 | 23 | 28 | 24 | 17 | |||||
Liabilities Current | 42 | 48 | 41 | 38 | 33 | 50 | 40 | 33 | 33 | 41 | 31 | 28 | |||||
Operating Lease Liability Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Derivative Liabilities Current | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Liabilities Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |||||
Deferred Income Tax Liabilities Net | 4 | 4 | 3 | 6 | 5 | 4 | 11 | - | - | 0 | - | 1 | |||||
Liabilities | 48 | 54 | 46 | 45 | 39 | 55 | 53 | 35 | 36 | 44 | 33 | 32 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Common Stock Value | 647 | 663 | 666 | 667 | 669 | 670 | 616 | 616 | 616 | 662 | 613 | 613 | |||||
Additional Paid In Capital | - | - | - | - | - | - | 52 | 49 | 48 | 48 | 47 | 45 | |||||
Retained Earnings Accumulated Deficit | 461 | 448 | 450 | 424 | 464 | 458 | 414 | 406 | 414 | 417 | 462 | 463 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -34 | -17 | -34 | -8 | -66 | -64 | -0 | -12 | -2 | 21 | -2 | 18 | |||||
Stockholders Equity | 1,074 | 1,094 | 1,083 | 1,082 | 1,115 | 1,111 | 1,131 | 1,056 | 1,073 | 1,096 | 1,120 | 1,137 | |||||
Minority Interest | 50 | 49 | 50 | 48 | 48 | 47 | 50 | -4 | -4 | -3 | -3 | -3 | |||||
Liabilities And Stockholders Equity | 1,172 | 1,197 | 1,178 | 1,175 | 1,154 | 1,166 | 1,184 | 1,091 | 1,109 | 1,140 | 1,150 | 1,168 | |||||
Allowance For Notes And Loans Receivable Current | - | - | 0 | - | - | - | - | - | - | - | - | - | |||||
Allowance For Notes And Loans Receivable Noncurren… | - | - | 5 | - | - | - | - | - | - | - | - | - | |||||
Common Stock Shares Issued | 376 | 382 | 383 | 384 | 385 | 383 | 382 | 382 | 382 | 381 | 381 | 381 | |||||
Shares Outstanding | 376 | 382 | 383 | 384 | 385 | 383 | 382 | 382 | 382 | 381 | 381 | 381 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.36% | 4.00% | - | - | - | - | - | - | - | - | - | - |
| 2025 | -1.00% | -5.00% | 2.50% | 14.54% | 15.86% | 11.01% | 0.00% | 7.69% | 12.55% | -10.49% | 0.75% | -1.50% |
| 2024 | -9.12% | -18.25% | -15.09% | -2.59% | -6.47% | -4.31% | -9.73% | -8.41% | -15.93% | -10.50% | -11.50% | 7.00% |
| 2023 | - | - | - | 12.57% | 14.29% | -1.71% | 5.00% | 4.50% | -2.00% | 25.48% | 13.94% | 39.42% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 21.87 | 19.59 | 22.45 | 24.65 | 27.80 | 18.84 | 24.24 | 28.29 | 28.19 | 22.54 | 30.03 | 33.12 | |||||
| Quick Ratio | 20.61 | 18.45 | 21.07 | 23.39 | 26.56 | 18.04 | 22.86 | 27.25 | 27.09 | 21.68 | 28.67 | 31.25 | |||||
| Working Capital | 885.46M | 895.90M | 881.08M | 889.54M | 885.53M | 886.41M | 919.61M | 902.22M | 908.80M | 891.91M | 887.80M | 896.85M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |||||
| Interest Coverage TTM | -0.39 | -0.44 | -0.50 | -1.27 | -1.36 | -1.47 | -1.60 | -1.36 | -1.47 | -1.66 | -1.85 | -2.27 | |||||
| Debt Ratio | 0.04 | 0.05 | 0.04 | 0.04 | 0.03 | 0.05 | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.18 | 0.16 | 0.15 | 0.15 | 0.15 | 0.14 | 0.13 | 0.13 | 0.11 | 0.10 | 0.09 | 0.08 | |||||
| Days Sales Outstanding TTM | 44.82 | 46.78 | 49.28 | 44.91 | 36.91 | 33.21 | 42.73 | 36.92 | 42.68 | 56.29 | 56.24 | 55.39 | |||||
| Receivables Turnover TTM | 8.14 | 7.80 | 7.41 | 8.13 | 9.89 | 10.99 | 8.54 | 9.89 | 8.55 | 6.48 | 6.49 | 6.59 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.00 | -0.02 | 0.09 | 0.05 | 0.13 | 0.11 | -0.12 | -0.15 | -0.15 | -0.19 | -0.28 | -0.38 | |||||
| Free Cash Flow Per Share TTM | 0.07 | 0.00 | -0.01 | -0.02 | -0.02 | 0.02 | 0.05 | 0.03 | -0.00 | -0.12 | -0.22 | -0.26 | |||||
| Dividend Per Share TTM | 0.04 | 0.04 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 32.40% | 32.46% | 32.57% | 24.53% | 20.46% | 15.57% | 10.54% | 11.74% | 10.43% | 9.90% | 9.77% | 9.71% | |||||
| Operating Profit Margin TTM | -7.20% | -9.00% | -12.07% | -31.29% | -38.40% | -47.29% | -56.13% | -52.77% | -61.96% | -70.51% | -76.03% | -86.98% | |||||
| Net Profit Margin TTM | 0.07% | -4.89% | 20.49% | 10.63% | 29.37% | 25.39% | -30.68% | -40.46% | -44.18% | -61.50% | -95.53% | -136.27% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 24.99% | 19.49% | 13.91% | 22.52% | 30.42% | 34.55% | 36.86% | 35.01% | 21.26% | 10.04% | -0.85% | -6.52% | |||||
| Net Income Growth (1Y) | -99.71% | -123.00% | -176.09% | -132.19% | -186.69% | -155.54% | -56.05% | -59.92% | -63.27% | -56.17% | -51.73% | 31.82% | |||||
| EPS Growth (1Y) | -99.71% | -122.91% | -175.93% | -131.93% | -186.35% | -155.38% | -56.19% | -60.04% | -63.34% | -56.63% | -52.11% | 30.12% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 6,705.84 | -106.76 | 29.50 | 39.80 | 14.02 | 18.79 | -17.65 | -15.50 | -17.46 | -10.77 | -7.06 | -5.24 | |||||
| P/B TTM | 0.85 | 0.88 | 0.94 | 0.65 | 0.62 | 0.69 | 0.74 | 0.84 | 0.93 | 0.73 | 0.68 | 0.66 | |||||
| P/S TTM | 4.53 | 5.22 | 6.05 | 4.23 | 4.12 | 4.77 | 5.41 | 6.27 | 7.71 | 6.62 | 6.75 | 7.14 | |||||
| Market Cap | 952.23M | 1.01B | 1.06B | 735.93M | 693.16M | 771.76M | 837.21M | 890.43M | 995.57M | 796.22M | 762.20M | 750.49M | |||||
| Enterprise Value | 130.37M | 216.73M | 280.81M | -58.48M | -104.66M | -87.05M | -24.83M | 42.24M | 140.45M | 126.93M | 190.54M | 341.07M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 26.53M | 149.00K | -5.37M | -9.03M | -6.99M | 6.43M | 17.85M | 12.49M | -793.00K | -45.36M | -85.68M | -100.45M | |||||
| Net Debt | -821.86M | -791.79M | -784.17M | -794.42M | -797.82M | -858.81M | -862.03M | -848.19M | -855.11M | -669.29M | -571.66M | -409.43M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Cronos Group Inc. (CRON) — SEC Financial Statements & Analysis
Cronos Group Inc. (CRON) is a medicinal chemicals & botanical products company, incorporated in A1. Cronos Group Inc. trades on CRON: Nasdaq as: CRON. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Cronos Group Inc. reported a 24.99% year-over-year revenue growth, a Gross Profit Margin of 32.40% (TTM), a Debt-to-Equity ratio of 0.04x, a Price-to-Sales (P/S) ratio of 4.53x (TTM), a Price-to-Book (P/B) ratio of 0.85 (TTM), at a market cap of $952.23M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 24.99%
- Gross Profit Margin TTM
- 32.40%
- Debt To Equity
- 0.04x
- P/S TTM
- 4.53x
- P/B TTM
- 0.85
- Market Cap
- $952.23M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Cronos Group Inc. in?
Cronos Group Inc. (CRON) operates in the Medicinal Chemicals & Botanical Products industry.
What is CRON's market cap?
Cronos Group Inc. (CRON) has a market capitalization of $952.23M as of 2026-03-31.
What is CRON's P/E ratio?
Cronos Group Inc. (CRON)'s trailing twelve month P/E ratio is 6705.84x as of 2026-03-31.
What exchange does CRON trade on?
Cronos Group Inc. (CRON) trades on the CRON: Nasdaq.
Where is Cronos Group Inc. incorporated?
Cronos Group Inc. is incorporated in British Columbia, Canada.